To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06005974
Title A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Recursion Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Sharp Memorial Hospital San Diego California 92123 United States Details
Sansum Clinic Santa Barbara California 93105 United States Details
Rocky Mountain Cancer Centers Denver Colorado 80218 United States Details
Eastern Connecticut Hematology & Oncology Associates Norwich Connecticut 06360 United States Details
Medical Oncology Hematology Consultants Newark Delaware 19713 United States Details
Cancer Specialists of North Florida Fleming Island Florida 32003 United States Details
Mission Cancer And Blood Des Moines Iowa 50314 United States Details
American Oncology Partners of Maryland, PA Bethesda Maryland 20817 United States Details
Saint Luke's Hospital Kansas City Missouri 64111 United States Details
Hunterdon Hematology Oncology Hillsborough New Jersey 08844 United States Details
Avera Cancer Institute Sioux Falls South Dakota 57105 United States Details
Mary Crowley Cancer Research Centers Dallas Texas 75231 United States Details
Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field